Markets, like tides, do not reverse without warning — and the Nifty 50 has been sending signals for weeks. After four consecutive weeks of decline and a break below its rising channel, India's benchmark index enters the coming week carrying the weight of weakening momentum, rising US bond yields, and geopolitical unease. Analyst Sudeep Shah of SBI Securities reads the technical evidence as a coherent story of fading conviction, with the 23,600–23,500 support zone standing as the next meaningful test of whether sellers or buyers will define the market's near-term character.
Nifty 50 poised to test 23,600-23,500 support as bears dominate: SBI Securities
The downtrend itself is gaining force, not losing it
Mark
So Sudeep Shah is saying the Nifty is more likely to break down than bounce up next week. What's the core of that argument?
Mimi
He's looking at the moving averages—the 20, 50, and 100-day EMAs are all sloping downward now, which means the trend is weakening. The index is trading below all of them. The RSI is stuck around 40, which is subdued. And the ADX has moved above 20 and is rising, which means the downtrend itself is strengthening.
Luke
But wait—if the ADX is rising, that means the trend is strong. That could be a strong downtrend or a strong uptrend. The fact that it's rising doesn't tell us which direction the market is actually going to go.
Mimi
Right, but the direction is already established. The index has closed lower for four consecutive weeks. It's broken below its rising channel. The RSI is below its 9-day average. All of those point downward.
Mark
What about the external factors he mentions—geopolitical tensions, bond yields, oil prices? Are those quantified anywhere in the analysis?
Luke
No, they're mentioned as context but not measured. We don't know how much of the selling is driven by each factor. It's an attribution, not a proof.
Mimi
Fair point. But the technical setup is independent of those factors. The moving averages would be sloping down regardless of what's happening geopolitically.
Mark
He mentions a recovery after testing 23,786. Why does he dismiss that as merely technical?
Mimi
Because it didn't hold. The index bounced but then fell back. A real reversal would show sustained strength above the moving averages and rising momentum indicators. This was just a bounce within a downtrend.
Luke
That's interpretation, though. We don't know if the recovery will hold or not. He's making a probabilistic call based on what he sees, but the future is still open.
Mark
What about the stocks he's recommending—Yatharth Hospital and KPR Mill? Are those bets against the broader market weakness?
Mimi
Not necessarily against it. They're sector-specific or stock-specific strength plays. Yatharth broke out from a consolidation range with volume support. KPR is trading above its moving averages with rising RSI. Those are independent of what Nifty does.
Luke
But if the market is heading down, how much room do individual stocks have to run? That's the real question.
Mimi
That's always the question. But the technical setup on those stocks is bullish independent of the index. Whether they outperform in a down market is a different bet.
Mark
And the Smallcap 100 is outperforming. Does that contradict the bearish view on Nifty?
Mimi
Not really. Different segments of the market can move differently. Smallcap is showing strength, Midcap is weak, Nifty is weak. It's a mixed market.
Luke
Which means the analysis is really about the large-cap index specifically, not the market as a whole. That's an important distinction.
Il Polso
- Four straight weeks of losses have broken the Nifty 50 below its rising channel, a structural crack that shifts the short-term trend decisively downward.
- Moving averages across three timeframes are all sloping lower, the RSI is languishing near 40, and the ADX is rising above 20 — a rare alignment of indicators all pointing the same direction: down.
- Geopolitical tensions, climbing US 10-year yields, and elevated crude oil prices are amplifying the selling pressure, turning every attempted rally into a distribution opportunity for cautious investors.
- The 23,750–23,700 Fibonacci support zone is the immediate battleground; a decisive break there opens the path to 23,500 and then 23,300, while recovery requires a sustained hold above 24,150–24,200.
- Even within the broader weakness, Nifty Pharma holds its uptrend and Nifty Smallcap 100 scaled a fresh all-time high last week, reminding investors that not all corners of the market are surrendering.
Markets, like tides, do not reverse without warning — and the Nifty 50 has been sending signals for weeks. After four consecutive weeks of decline and a break below its rising channel, India's benchmark index enters the coming week carrying the weight of weakening momentum, rising US bond yields, and geopolitical unease. Analyst Sudeep Shah of SBI Securities reads the technical evidence as a coherent story of fading conviction, with the 23,600–23,500 support zone standing as the next meaningful test of whether sellers or buyers will define the market's near-term character.
India's Nifty 50 is entering the coming week in a fragile technical state. Four consecutive weeks of decline have pushed the index below the rising channel that had structured its prior advance, and the move carries the hallmarks of a trend shift rather than a routine pullback. Sudeep Shah, who leads technical and derivatives research at SBI Securities, places the probability of a break below the 23,600–23,500 support zone well above the probability of any meaningful rally toward 24,000 and beyond.
The technical case for caution is unusually consistent. The 20, 50, and 100-day exponential moving averages have all turned lower, the daily RSI is hovering near 40 and trailing its own signal line, and the ADX has climbed above 20 and continues to rise — a sign that the downtrend is strengthening rather than exhausting itself. A modest bounce from the 23,786 level last week offered little reassurance; Shah reads it as a technical rebound within a downtrend, lacking the volume and follow-through that genuine reversals require.
External pressures are compounding the internal weakness. Escalating geopolitical tensions, rising US bond yields, and elevated Brent crude prices have all contributed to a climate in which investors are reluctant to commit at higher levels. The immediate support at 23,750–23,700 — which coincides with the 61.8 percent Fibonacci retracement of the prior rally — is the first line of defense. If it fails, 23,500 and then 23,300 become the next reference points. On the upside, the convergence of the 50-day and 100-day moving averages near 24,150–24,200 forms a formidable ceiling.
Not everything is retreating. Nifty Pharma continues to post higher highs and higher lows, its primary uptrend intact. The Nifty Smallcap 100 outperformed last week, closing positive and touching a fresh all-time high after finding support along its rising trendline — a sign of genuine buying interest at lower levels. Shah also identifies two stock-specific opportunities: Yatharth Hospital, which broke out of a months-long consolidation with rising volume and an RSI above 60, with a target near 1,065 rupees; and KPR Mill, which has pulled back constructively to its 34-day EMA with momentum indicators turning higher, targeting 1,270 rupees. Both carry defined stop-losses for risk management.
The week ahead, in Shah's reading, is less about opportunity in the headline index and more about watching whether key supports hold — or give way to the next leg of a trend that has been building its bearish case quietly but persistently.
The Indian stock market's benchmark index is showing signs of serious weakness heading into the week ahead. Nifty 50 has closed lower for four straight weeks, a stretch of persistent selling that suggests investors are losing conviction at higher price levels. The index has broken below the rising channel that had contained it on daily charts, a technical deterioration that signals the short-term trend is shifting downward. Sudeep Shah, head of technical and derivatives research at SBI Securities, sees the probability of the index testing and breaking below the 23,600 to 23,500 support zone as significantly higher than any sustained rally above 24,000 to 24,200 in the coming week.
The technical picture supporting this bearish view is layered and consistent. Nifty is now trading below its key short and medium-term moving averages—the 20, 50, and 100-day exponential moving averages have all begun to slope downward, a pattern that reflects fading price strength. The daily RSI, a momentum gauge, is hovering near 40 and remains below its own 9-day average, indicating that bullish momentum has largely evaporated. The ADX, which measures trend strength, has moved above 20 and is rising, suggesting the current downward trend is actually gaining force rather than losing steam. Taken together, these indicators paint a picture of an index caught in a weakening grip.
External forces are adding weight to the selling pressure. Escalating geopolitical tensions, rising US 10-year bond yields, and elevated Brent crude oil prices have all weighed on investor sentiment in recent weeks. While Nifty did stage a modest recovery after testing the 23,786 level, Shah characterizes this rebound as technical in nature—a bounce within a downtrend rather than the beginning of a meaningful reversal. The recovery lacked the conviction and follow-through that would signal a genuine shift in market direction.
From a technical levels perspective, the immediate support zone sits at 23,750 to 23,700, a range that coincides with the 61.8 percent Fibonacci retracement of the prior rally from 23,070 to 24,774. If this support breaks decisively, further weakness toward 23,500 becomes likely, with 23,300 as the next potential floor. On the upside, strong resistance is positioned around 24,150 to 24,200, where the 50-day and 100-day moving averages converge. Unless Nifty manages to sustain above this hurdle, the prevailing bearish bias is expected to persist.
Within this broader weakness, Shah identifies pockets of strength worth watching. Nifty Pharma continues to maintain a sequence of higher highs and higher lows, indicating the primary uptrend in that sector remains intact, even as near-term momentum has moderated. The Nifty Smallcap 100 significantly outperformed broader indices last week, ending in positive territory and scaling a fresh all-time high after finding support near its upward-sloping trendline. The index formed a small-bodied candle with a lower shadow on the weekly chart, a pattern suggesting buying interest at lower levels. Key technical indicators continue to point to robust bullish undertone in the small-cap space.
For stock-specific opportunities, Shah recommends accumulating Yatharth Hospital and Trauma Care Services in the 985 to 995 rupee zone, with a stop-loss at 955. The stock broke out from a consolidation range that had held since May, supported by healthy volume increases, and continues to trade above key moving averages. The ADX is rising on both weekly and daily timeframes, and the RSI has turned higher and settled comfortably above 60, signaling renewed bullish momentum. The stock could test 1,065 rupees in the short term. KPR Mill is the second pick, recommended for accumulation between 1,175 and 1,190 rupees with a stop-loss at 1,140. The stock trades above key moving averages, has experienced a strong pullback from its 34-day EMA, and shows RSI in rising mode on both timeframes, indicating healthy bullish momentum. It could test 1,270 rupees near term.
The broader market setup suggests a week of testing and potential breaking of key support levels, with the technical evidence pointing decidedly toward downside risk rather than upside opportunity for the main index.
Citazioni salienti
The probability of Nifty 50 breaking below the 23,600-23,500 zone appears higher than a sustained move above the 24,000-24,200 zone in the coming week— Sudeep Shah, SBI Securities
The rebound appears more technical in nature rather than the start of a meaningful trend reversal— Sudeep Shah, on the modest recovery after testing 23,786
Vuoi la storia completa?
Leggi l'originale su Moneycontrol ↗
Economy & Finance